JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M501374200 on March 17, 2005

J. Biol. Chem., Vol. 280, Issue 25, 23643-23652, June 24, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/25/23643    most recent
M501374200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Okhrimenko, H.
Right arrow Articles by Brodie, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Okhrimenko, H.
Right arrow Articles by Brodie, C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Roles of Tyrosine Phosphorylation and Cleavage of Protein Kinase C{delta} in Its Protective Effect Against Tumor Necrosis Factor-related Apoptosis Inducing Ligand-induced Apoptosis*

Hana Okhrimenko{ddagger}, Wei Lu§, Cunli Xiang§, Donghong Ju§, Peter M. Blumberg¶, Ruth Gomel{ddagger}, Gila Kazimirsky{ddagger}, and Chaya Brodie{ddagger}§||

From the {ddagger}Gonda (Goldschmied) Medical Diagnosis Research Center, Faculty of Life-Sciences, Bar-Ilan University, Ramat-Gan, Israel 52900, the §Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Hospital, Detroit, Michigan 48202, and the Laboratory of Cellular Carcinogenesis and Tumor Promotion, NCI, National Institutes of Health, Bethesda, Maryland 20892

Protein kinase C{delta} (PKC{delta}) regulates cell apoptosis in a cell- and stimulus-specific manner. Here, we studied the role of PKC{delta} in the apoptotic effect of TRAIL in glioma cells. We found that transfection of the cells with a PKC{delta} kinase-dead mutant (K376R) or with a small interfering RNA targeting the PKC{delta} mRNA increased the apoptotic effect of tumor necrosis factor-related apoptosis inducing ligand (TRAIL), whereas overexpression of PKC{delta} decreased it. PKC{delta} acted downstream of caspase 8 and upstream of cytochrome c release from the mitochondria. TRAIL induced cleavage of PKC{delta} within 2–3 h of treatment, which was abolished by caspase 3, 8, and 9 inhibitors. The cleavage of PKC{delta} was essential for its protective effect because overexpression of a caspase-resistant mutant (PKC{delta}D327A) did not protect glioma cells from TRAIL-induced apoptosis but rather increased it. TRAIL induced translocation of PKC{delta} to the perinuclear region and the endoplasmic reticulum and phosphorylation of PKC{delta} on tyrosine 155. Using a PKC{delta}Y155F mutant, we found that the phosphorylation of PKC{delta} on tyrosine 155 was essential for the cleavage of PKC{delta} in response to TRAIL and for its translocation to the endoplasmic reticulum. In addition, phosphorylation of PKC{delta} on tyrosine 155 was necessary for the activation of AKT in response to TRAIL. Our results indicate that PKC{delta} protects glioma cells from the apoptosis induced by TRAIL and implicate the phosphorylation of PKC{delta} on tyrosine 155 and its cleavage as essential factors in the anti-apoptotic effect of PKC{delta}.


Received for publication, February 7, 2005 , and in revised form, March 15, 2005.

* This work was supported by a grant from the James S. McDonnell Foundation 21st Century Scientist Award/Brain Cancer Research (to C. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

|| To whom correspondence should be addressed: Hermelin Brain Tumor Center, Dept. of Neurosurgery, Henry Ford Hospital, Detroit, MI 48202. E-mail: chaya{at}mail.biu.ac.il.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
S. L. Lomonaco, S. Kahana, M. Blass, Y. Brody, H. Okhrimenko, C. Xiang, S. Finniss, P. M. Blumberg, H.-K. Lee, and C. Brodie
Phosphorylation of Protein Kinase C{delta} on Distinct Tyrosine Residues Induces Sustained Activation of Erk1/2 via Down-regulation of MKP-1: ROLE IN THE APOPTOTIC EFFECT OF ETOPOSIDE
J. Biol. Chem., June 20, 2008; 283(25): 17731 - 17739.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
R. Gomel, C. Xiang, S. Finniss, H. K. Lee, W. Lu, H. Okhrimenko, and C. Brodie
The Localization of Protein Kinase C{delta} in Different Subcellular Sites Affects Its Proapoptotic and Antiapoptotic Functions and the Activation of Distinct Downstream Signaling Pathways
Mol. Cancer Res., June 1, 2007; 5(6): 627 - 639.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Xia, L. W. Forman, and D. V. Faller
Protein Kinase C{delta} Is Required for Survival of Cells Expressing Activated p21RAS
J. Biol. Chem., May 4, 2007; 282(18): 13199 - 13210.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. H. Choi, T. Hyman, and P. M. Blumberg
Differential Effect of Bryostatin 1 and Phorbol 12-Myristate 13-Acetate on HOP-92 Cell Proliferation Is Mediated by Down-regulation of Protein Kinase C{delta}.
Cancer Res., July 15, 2006; 66(14): 7261 - 7269.
[Abstract] [Full Text] [PDF]


Home page
Neuro OncolHome page
C. Billecke, S. Finniss, L. Tahash, C. Miller, T. Mikkelsen, N. P. Farrell, and O. Bogler
Polynuclear platinum anticancer drugs are more potent than cisplatin and induce cell cycle arrest in glioma
Neuro-oncol, July 1, 2006; 8(3): 215 - 226.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Rosenzweig, A. Ziv-Av, C. Xiang, W. Lu, S. Cazacu, D. Taler, C. G. Miller, R. Reich, Y. Shoshan, Y. Anikster, et al.
Related to Testes-Specific, Vespid, and Pathogenesis Protein-1 (RTVP-1) Is Overexpressed in Gliomas and Regulates the Growth, Survival, and Invasion of Glioma Cells.
Cancer Res., April 15, 2006; 66(8): 4139 - 4148.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.